A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants

Summary

The main purpose of this study is to evaluate how much of the study drug (LY3473329), administered as a single dose that has the radioactive substance 14C incorporated into it, passes from blood into urine, feces and expired air in healthy male participants. The study will also measure how much of the study drug gets into the bloodstream when taken orally, compared to when injected directly into the vein, how its broken down, and how long it takes the body to get rid of it. The study is conducted in two parts. The study will last up to approximately 9 and 7 weeks for part 1 and 2, respectively.

Timeline

Start

2024-03-05

Primary completion

2024-05-01

Completion

2024-05-01

Drugs

Indications

No indication recorded.